Cargando…

DNA methylation profile of liver tissue in end-stage cholestatic liver disease

AIMS: In this methylome-wide association study of cholestatic liver diseases (primary sclerosing cholangitis and primary biliary cholangitis), the authors aimed to elucidate changes in methylome and pathway enrichment to identify candidate genes. PATIENTS & METHODS: Reduced representation bisulf...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Angela C, Juran, Brian D, Schlicht, Erik M, McCauley, Bryan M, Atkinson, Elizabeth J, Moore, Raymond, Heimbach, Julie K, Watt, Kymberly D, Wu, Tsung-Teh, LaRusso, Nicholas F, Gores, Gregory J, Sun, Zhifu, Lazaridis, Konstantinos N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096606/
https://www.ncbi.nlm.nih.gov/pubmed/35473391
http://dx.doi.org/10.2217/epi-2021-0343
Descripción
Sumario:AIMS: In this methylome-wide association study of cholestatic liver diseases (primary sclerosing cholangitis and primary biliary cholangitis), the authors aimed to elucidate changes in methylome and pathway enrichment to identify candidate genes. PATIENTS & METHODS: Reduced representation bisulfite sequencing was performed on liver tissue from 58 patients with primary sclerosing cholangitis (n = 13), primary biliary cholangitis (n = 20), alcoholic liver disease (n = 21) and live liver donors (n = 4). Pathway enrichment and network analysis were used to explore key genes/pathways. RESULTS: Both cholestatic liver diseases were characterized by global hypomethylation, with pathway enrichment demonstrating distinct genes and pathways associated with the methylome. CONCLUSIONS: This novel study demonstrated that differential methylation in cholestatic liver disease was associated with unique pathways, suggesting it may drive disease pathogenesis.